| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/26/2006 | US7154001 Formate salt of O-desmethyl-venlafaxine |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153836 Having 1-4 hydrophobic C 10-24 aliphatic, saturated or unsaturated hydrocarbon residue moieties covalently bound to a protein with a hedgehog N-terminal domain; includes auxiliary substances, detergents, stabilizers, matrix materials, suramin, heparin, anionic polysaccharides and/or sequestering agents |
| 12/26/2006 | US7153686 Compositions of enriched central nervous system stem cell and progenitor cell populations |
| 12/21/2006 | US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286043 Delivery of antihistamines through an inhalation route |
| 12/21/2006 | US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 12/21/2006 | CA2550604A1 Methods for treating smooth muscle disorders using trospium |
| 12/21/2006 | CA2550603A1 Methods for treating smooth muscle disorders using trospium |
| 12/20/2006 | EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol" |
| 12/20/2006 | EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders |
| 12/20/2006 | EP1444329B1 Stem cells that transform to beating cardiomyocytes |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/19/2006 | US7151109 Psychological disorders; anxiolytic agents; antidepressants |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |
| 12/19/2006 | US7151098 Glutamate receptor antagonists |
| 12/14/2006 | WO2006132205A1 Radical scavenger and active oxygen eliminating agent |
| 12/14/2006 | WO2006132189A1 Screening method for neuronal differentiation inducer |
| 12/14/2006 | WO2006130982A1 Compositions and methods for enhancing nitric oxide delivery |
| 12/14/2006 | WO2006130949A1 Anti amyloid-related disease molecules and their uses |
| 12/14/2006 | WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal |
| 12/14/2006 | WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 12/14/2006 | US20060281887 (Meth)acrylate copolymer for use as medical carrier |
| 12/14/2006 | US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/14/2006 | US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/14/2006 | US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/14/2006 | US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns |
| 12/14/2006 | CA2820200A1 Compositions and methods for enhancing nitric oxide delivery |
| 12/14/2006 | CA2611140A1 Compositions and methods for enhancing nitric oxide delivery |
| 12/13/2006 | EP1731529A1 Calcium ion leakage inhibitors |
| 12/13/2006 | EP1729793A1 Alk7 and myostatin inhibitors and uses thereof |
| 12/13/2006 | EP1446127B1 Triazepine derivatives as neurotrophic agents |
| 12/13/2006 | EP1206554B1 Activatable recombinant neurotoxins |
| 12/13/2006 | CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same |
| 12/12/2006 | US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 12/12/2006 | US7148012 Therapeutic agent for fibromyalgia |
| 12/12/2006 | CA2234480C Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities |
| 12/12/2006 | CA2225284C Colchicine derivatives, the use thereof and formulations containing them |
| 12/07/2006 | WO2006129784A1 INTERFERON-α REGULATOR |
| 12/07/2006 | WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative |
| 12/07/2006 | WO2006129569A1 Muscle fiber type switching inhibitor |
| 12/07/2006 | US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38 |
| 12/07/2006 | US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276415 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/07/2006 | US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides |
| 12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
| 12/06/2006 | EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof |
| 12/06/2006 | EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 12/06/2006 | CN1872118A Application of Korean ginseng extractive in preventing and treating disease of muscular dystrophy |
| 12/06/2006 | CN1288159C Novel anticonvulsant derivative salts |
| 12/06/2006 | CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 12/06/2006 | CN1287783C Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 12/05/2006 | US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents |
| 12/05/2006 | US7144908 Prophylaxis, therapy of respiratory system disorders |
| 12/05/2006 | US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 12/05/2006 | US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent |
| 12/05/2006 | CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 11/30/2006 | WO2006127930A2 Nk-b inhibitors for the treatment of muscular dystrophy |
| 11/30/2006 | WO2006126541A1 Pharmaceutical composition comprising vitamin k |
| 11/30/2006 | WO2006107902A3 Use of spirostenols to treat mitochondrial disorders |
| 11/30/2006 | US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 11/30/2006 | US20060270681 Pyridazine derivatives |
| 11/30/2006 | US20060270649 Azetidine derivatives, their preparation and medicaments containing them |
| 11/30/2006 | US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use |
| 11/30/2006 | US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 11/30/2006 | CA2613337A1 Nk-b inhibitors for the treatment of muscular dystrophy |
| 11/29/2006 | EP1726651A1 Method of treating muscular disorders |
| 11/29/2006 | EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 11/29/2006 | EP1259223A4 Protein matrix materials, devices and methods of making and using thereof |
| 11/29/2006 | EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 11/29/2006 | EP1196598B1 Dsp-3 dual-specificity phosphatase |
| 11/29/2006 | EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide |
| 11/29/2006 | EP0605501B2 Use of presynaptic neurotoxin for the treatment of cerebral palsy |
| 11/29/2006 | CN1871000A Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 11/29/2006 | CN1869072A Nerve growth factor combined with collagen specificity and its coading gene and application |
| 11/29/2006 | CN1869068A Corticotropin releasing factor 2 receptor agonists |
| 11/29/2006 | CN1286834C Benzothiazoles compound |
| 11/29/2006 | CN1286524C Use of OPN for treatment and/or prevention of neurological diseases |
| 11/28/2006 | US7141656 In situ screening, isolation of peptides; major histocompability complex |
| 11/28/2006 | US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 11/28/2006 | US7141580 activity as prostaglandin E2 receptor antagonists |
| 11/28/2006 | US7141383 EDG8 receptor, its preparation and use |
| 11/28/2006 | US7141363 Purposeful movement of human migratory cells away from an agent source |
| 11/28/2006 | US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 11/28/2006 | CA2275379C Use of pramipexole in the treatment of restless legs syndrome |
| 11/23/2006 | WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 11/23/2006 | WO2006123724A1 Novel pharmaceutical using anti-hla antibody |
| 11/23/2006 | WO2006123675A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 11/23/2006 | WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 11/23/2006 | US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors |
| 11/23/2006 | US20060264456 Phosphorus-containing compounds & uses thereof |